3. ABSTRACT
Measles is a vaccine-preventable disease whose vaccine was introduced in the United Kingdom in 1988, however, Measles outbreaks are still occurring in England. Consequently, the World Health Organization (WHO) removed the UK’s elimination status of Measles in 2019.
Noticeably, MMR vaccination coverage in England is below the recommended threshold with geographical variations across local authorities (LA). The research into the effect of income disparities on MMR vaccine coverage was insufficiently examined. Therefore, an ecological study will be conducted aiming at determining whether there is a relationship between income deprivation measures and MMR vaccine coverage in upper-tier local authorities in England, using 2019 publicly available data. The effect of spatial clustering of income level on vaccination coverage will also be assessed.
Vaccination coverage data will be obtained from “Cover of Vaccination Evaluated Rapidly (COVER)”. Income deprivation score, Deprivation gap, and Income Deprivation Affecting Children Index will be obtained from Office for National Statistics and Moran’s Index will be generated using RStudio.
Rural/urban LA classification and mothers’ education will be included as possible confounding factors. Additionally, the live births rate per mothers’ age group will be included as a proxy for the mothers’ age variation in different LA. Multiple linear regression will be used after testing the relevant assumptions, using SPSS software. Moran’s I together with income deprivation score will be analysed through regression and mediation analysis.
This study will help in determining whether income level is a determinant of MMR vaccination uptake and coverage in LA in England which would help policymakers in designing targeted campaigns, thus preventing measles outbreaks in the future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
FUNDING STATEMENT: ‘This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.’
Data Availability
Collated research data will be made publicly available when the study is completed and published.
